These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 18789789)

  • 1. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V; Hamon M
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action.
    Zhong H; Haddjeri N; Sánchez C
    Psychopharmacology (Berl); 2012 Jan; 219(1):1-13. PubMed ID: 21901317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Kinases Alter the Allosteric Modulation of the Serotonin Transporter In Vivo and In Vitro.
    Mnie-Filali O; Lau T; Matthaeus F; Abrial E; Delcourte S; El Mansari M; Pershon A; Schloss P; Sánchez C; Haddjeri N
    CNS Neurosci Ther; 2016 Aug; 22(8):691-9. PubMed ID: 27171685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.
    Jacobsen JP; Plenge P; Sachs BD; Pehrson AL; Cajina M; Du Y; Roberts W; Rudder ML; Dalvi P; Robinson TJ; O'Neill SP; Khoo KS; Morillo CS; Zhang X; Caron MG
    Psychopharmacology (Berl); 2014 Dec; 231(23):4527-40. PubMed ID: 24810106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escitalopram: a unique mechanism of action.
    Bræstrup C; Sanchez C
    Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():11-3. PubMed ID: 24930683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
    Chen F; Larsen MB; Sánchez C; Wiborg O
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):193-8. PubMed ID: 15695064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.
    Guiard BP; Mansari ME; Murphy DL; Blier P
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):349-61. PubMed ID: 21439106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo investigation of escitalopram's allosteric site on the serotonin transporter.
    Murray KE; Ressler KJ; Owens MJ
    Pharmacol Biochem Behav; 2016 Feb; 141():50-7. PubMed ID: 26621784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
    Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant.
    Zhong H; Hansen KB; Boyle NJ; Han K; Muske G; Huang X; Egebjerg J; Sánchez C
    Neurosci Lett; 2009 Oct; 462(3):207-12. PubMed ID: 19616061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The allosteric citalopram binding site differentially interferes with neuronal firing rate and SERT trafficking in serotonergic neurons.
    Matthäus F; Haddjeri N; Sánchez C; Martí Y; Bahri S; Rovera R; Schloss P; Lau T
    Eur Neuropsychopharmacol; 2016 Nov; 26(11):1806-1817. PubMed ID: 27665061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Escitalopram and citalopram: the unexpected role of the R-enantiomer].
    Jacquot C; David DJ; Gardier AM; Sánchez C
    Encephale; 2007; 33(2):179-87. PubMed ID: 17675913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram.
    Sánchez C
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):91-5. PubMed ID: 16918708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain.
    El Mansari M; Sánchez C; Chouvet G; Renaud B; Haddjeri N
    Neuropsychopharmacology; 2005 Jul; 30(7):1269-77. PubMed ID: 15702136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.
    Klein N; Sacher J; Geiss-Granadia T; Mossaheb N; Attarbaschi T; Lanzenberger R; Spindelegger C; Holik A; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2007 Apr; 191(2):333-9. PubMed ID: 17235610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-D-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat.
    Schilström B; Konradsson-Geuken A; Ivanov V; Gertow J; Feltmann K; Marcus MM; Jardemark K; Svensson TH
    Synapse; 2011 May; 65(5):357-67. PubMed ID: 20730799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice.
    Nguyen HT; Guiard BP; Bacq A; David DJ; David I; Quesseveur G; Gautron S; Sanchez C; Gardier AM
    Br J Pharmacol; 2013 Jan; 168(1):103-16. PubMed ID: 22233336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.